...
首页> 外文期刊>Stroke Research and Treatment >Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
【24h】

Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma

机译:假定的心室粘液瘤对大脑中部和视网膜动脉的阻塞进行静脉溶栓治疗

获取原文
           

摘要

Background. Although thrombolytic therapy has been shown to be beneficial to stroke patients, the effectiveness of intravenous thrombolysis in ischemic stroke patients with ventricle myxoma is unknown.Case Description. A 22-year-old woman with left hemiplegia was sent to the emergency department at a teaching hospital. The magnetic resonance angiography showed occlusion of the right middle cerebral artery, and the echocardiography showed a mass in the left ventricle. Intravenous recombined tissue plasminogen activator (rt-PA) was administrated, and the postthrombolysis transcranial Doppler exam showed that her right middle cerebral artery was circulative. The patient's condition improved gradually, and no complication was observed up to 16 months of follow-up.Conclusion. Intravenous rt-PA is a reasonable treatment for stroke patients with ventricle myxoma.
机译:背景。尽管已显示溶栓治疗对中风患者有益,但尚不清楚在缺血性中风并发心室粘液瘤的患者中静脉溶栓治疗的有效性。一名患有左偏瘫的22岁妇女被送往教学医院的急诊室。磁共振血管造影显示右大脑中动脉闭塞,超声心动图显示左心室有肿块。静脉注射重组组织纤溶酶原激活剂(rt-PA),溶栓后经颅多普勒检查显示她的右大脑中动脉循环。患者的病情逐渐好转,在随访的16个月内未观察到并发症。 rt-PA静脉注射是卒中合并心室粘液瘤的合理治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号